Who are Affini-T's investors?

Affini-T's investors include Agent Capital, Olive Tree Capital, Service Provider Capital, Fred Hutchinson Cancer Research Center, Humboldt, Leaps by Bayer, Vida Ventures.

How much funding has Affini-T raised?

Affini-T has disclosed $175M raised across 1 of its 2 known rounds.

Affini-T

8 employees on LinkedIn · 8 known investors

Find your way into Affini-T

Your email: who you already know at Affini-T, and who your contacts know
2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Affini-T team
Your LinkedIn: the connections who can make the intro for you

We rank every route by how warm it is, so you raise on warm intros instead of cold emails.

Affini-T Therapeutics develops TCR-based immunotherapies aimed at treating solid tumors, using two complementary therapeutic modalities. The company operates in the biotech and cancer immunotherapy space.

Biotech Healthtech Longevity

Investors · 8

Agent Capitallisted by Agent CapitalWaltham

How we know: Agent Capital's portfolio page · the VCSheet dataset · Not right? Tell us

Olive Tree Capitallisted by Olive Tree CapitalBoston

How we know: Olive Tree Capital's portfolio page · the VCSheet dataset · Not right? Tell us

Service Provider Capitallisted by Service Provider CapitalVail

Fred Hutchinson Cancer Research Centerreported

How we know: cen.acs.org · Not right? Tell us

HumboldtreportedNew York · $100K – $5M

How we know: the VCSheet dataset · Not right? Tell us

Leaps by BayerreportedLeverkusen

How we know: funding news · businessinsider.com · Not right? Tell us

Vida VenturesreportedLos Angeles

How we know: funding news · fiercebiotech.com · Not right? Tell us

Also in the syndicate · 1

Leapslead

Funding

SEC filings, press & company announcements

$175M disclosed across 1 of 2 rounds · 2022

Undisclosed amountSeries A and BMar 2022
Leaps by Bayer (lead), Vida Ventures (lead)
Source ↗
$175MraisedMar 2022 · 3 sources
Leaps (lead), Vida Ventures (lead), Fred Hutchinson Cancer Research Center
Source ↗

Source: company announcements and press reports — follow each round's link for the claim.

Frequently asked questions

What does Affini-T do?: Affini-T Therapeutics develops TCR-based immunotherapies aimed at treating solid tumors, using two complementary therapeutic modalities. The company operates in the biotech and cancer immunotherapy space.
Who are Affini-T's investors?: Affini-T's investors include Agent Capital, Olive Tree Capital, Service Provider Capital, Fred Hutchinson Cancer Research Center, Humboldt, Leaps by Bayer, Vida Ventures.
How much funding has Affini-T raised?: Affini-T has disclosed $175M raised across 1 of its 2 known rounds.